Neurocrine Biosciences Shares Outstanding 2006-2020 | NBIX

Neurocrine Biosciences shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Neurocrine Biosciences shares outstanding for the quarter ending September 30, 2020 were 0.093B, a 2.91% decline year-over-year.
  • Neurocrine Biosciences 2019 shares outstanding were 0.096B, a 0.36% increase from 2018.
  • Neurocrine Biosciences 2018 shares outstanding were 0.095B, a 8.28% increase from 2017.
  • Neurocrine Biosciences 2017 shares outstanding were 0.088B, a 1.59% increase from 2016.
Neurocrine Biosciences Annual Shares Outstanding
(Millions of Shares)
2019 96
2018 95
2017 88
2016 87
2015 84
2014 75
2013 67
2012 67
2011 56
2010 53
2009 39
2008 38
2007 38
2006 38
2005 37
Neurocrine Biosciences Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 93
2020-06-30 98
2020-03-31 97
2019-12-31 96
2019-09-30 96
2019-06-30 95
2019-03-31 91
2018-12-31 95
2018-09-30 97
2018-06-30 90
2018-03-31 90
2017-12-31 88
2017-09-30 88
2017-06-30 88
2017-03-31 87
2016-12-31 87
2016-09-30 87
2016-06-30 87
2016-03-31 86
2015-12-31 84
2015-09-30 86
2015-06-30 86
2015-03-31 80
2014-12-31 75
2014-09-30 76
2014-06-30 76
2014-03-31 70
2013-12-31 67
2013-09-30 67
2013-06-30 67
2013-03-31 67
2012-12-31 67
2012-09-30 66
2012-06-30 66
2012-03-31 63
2011-12-31 56
2011-09-30 56
2011-06-30 56
2011-03-31 56
2010-12-31 53
2010-09-30 56
2010-06-30 55
2010-03-31 47
2009-12-31 39
2009-09-30 39
2009-06-30 39
2009-03-31 39
2008-12-31 38
2008-09-30 38
2008-06-30 38
2008-03-31 38
2007-12-31 38
2007-09-30 38
2007-06-30 38
2007-03-31 38
2006-12-31 38
2006-09-30 38
2006-06-30 38
2006-03-31 37
2005-12-31 37
2005-09-30 38
2005-06-30 37
2005-03-31 37
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $10.104B $0.788B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.970B 41.96
Takeda Pharmaceutical (TAK) Japan $56.939B 10.62
Astellas Pharma (ALPMY) Japan $29.602B 18.49
Merck (MKGAF) Germany $22.933B 0.00
Eisai (ESALY) Japan $21.762B 18.96
UCB SA (UCBJF) Belgium $20.831B 0.00
Catalent (CTLT) United States $18.899B 56.53
Grifols, S.A (GRFS) Spain $13.235B 15.16
Jazz Pharmaceuticals (JAZZ) Ireland $9.081B 14.67
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.772B 0.00
Ionis Pharmaceuticals (IONS) United States $8.340B 81.71
Arrowhead Pharmaceuticals (ARWR) United States $8.323B 0.00
United Therapeutics (UTHR) United States $7.204B 15.34
IPSEN SA ADR (IPSEY) France $7.040B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.853B 396.78
Sage Therapeutics (SAGE) United States $5.008B 0.00
PTC Therapeutics (PTCT) United States $4.547B 0.00
ChemoCentryx (CCXI) United States $4.271B 0.00
Hypermarcas (HYPMY) Brazil $4.117B 15.12
Cronos Group (CRON) Canada $3.807B 0.00
FibroGen (FGEN) United States $3.581B 0.00
Nektar Therapeutics (NKTR) United States $3.288B 0.00
Pacira BioSciences (PCRX) United States $3.193B 69.33
Corcept Therapeutics (CORT) United States $3.133B 30.30
Taro Pharmaceutical Industries (TARO) Israel $2.946B 15.04
Xencor (XNCR) United States $2.754B 0.00
Revolution Medicines (RVMD) United States $2.540B 0.00
Tilray (TLRY) Canada $2.006B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.804B 15.44
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.758B 0.00
Translate Bio (TBIO) United States $1.706B 0.00
Endo (ENDP) Ireland $1.663B 2.52
USANA Health Sciences (USNA) United States $1.660B 14.61
Heron Therapeutics (HRTX) United States $1.650B 0.00
Ocular Therapeutix (OCUL) United States $1.617B 0.00
Trillium Therapeutics (TRIL) Canada $1.465B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.439B 0.00
ImmunoGen (IMGN) United States $1.423B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.421B 9.88
Karyopharm Therapeutics (KPTI) United States $1.112B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.108B 0.00
Zogenix (ZGNX) United States $1.057B 0.00
Radius Health (RDUS) United States $1.029B 0.00
Indivior (INVVY) United States $1.029B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.937B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Acutus Medical (AFIB) United States $0.794B 0.00
ORGANOGENESIS (ORGO) United States $0.791B 0.00
Collegium Pharmaceutical (COLL) United States $0.755B 44.55
Esperion Therapeutics (ESPR) United States $0.750B 0.00
VAXART, INC (VXRT) United States $0.742B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.719B 0.00
Aerie Pharmaceuticals (AERI) United States $0.668B 0.00
Chinook Therapeutics (KDNY) United States $0.652B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.634B 0.00
Ardelyx (ARDX) United States $0.626B 0.00
Flexion Therapeutics (FLXN) United States $0.580B 0.00
Siga Technologies (SIGA) United States $0.564B 15.85
Harpoon Therapeutics (HARP) United States $0.540B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.536B 0.00
Molecular Templates (MTEM) United States $0.533B 0.00
PROFOUND MEDICL (PROF) Canada $0.472B 0.00
Sundial Growers (SNDL) Canada $0.465B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.465B 0.00
Altimmune (ALT) United States $0.453B 0.00
Akebia Therapeutics (AKBA) United States $0.450B 0.00
Summit Therapeutics (SMMT) United States $0.436B 0.00
TherapeuticsMD (TXMD) United States $0.426B 0.00
DURECT (DRRX) United States $0.423B 0.00
CASI Pharmaceuticals (CASI) United States $0.404B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.391B 0.00
Rafael Holdings (RFL) United States $0.381B 0.00
Concert Pharmaceuticals (CNCE) United States $0.375B 0.00
Innate Pharma SA (IPHYF) France $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.365B 9.51
Matinas Biopharma Holdings (MTNB) United States $0.321B 0.00
MEI Pharma (MEIP) United States $0.316B 0.00
Alpine Immune Sciences (ALPN) United States $0.315B 0.00
Nature's Sunshine Products (NATR) United States $0.299B 19.23
Jaguar Animal Health (JAGX) United States $0.297B 0.00
KalVista Pharmaceuticals (KALV) United States $0.294B 0.00
Jounce Therapeutics (JNCE) United States $0.292B 0.00
Redhill Biopharma (RDHL) Israel $0.282B 0.00
Xeris Pharmaceuticals (XERS) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.280B 7.37
Menlo Therapeutics (VYNE) United States $0.274B 0.00
Otonomy (OTIC) United States $0.271B 0.00
Aclaris Therapeutics (ACRS) United States $0.252B 0.00
CTI BioPharma (CTIC) United States $0.249B 0.00
OptiNose (OPTN) United States $0.222B 0.00
IMV INC (IMV) Canada $0.221B 0.00
Calithera Biosciences (CALA) United States $0.212B 0.00
Oncternal Therapeutics (ONCT) United States $0.199B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
ProPhase Labs (PRPH) United States $0.182B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Aquestive Therapeutics (AQST) United States $0.178B 0.00
Infinity Pharmaceuticals (INFI) United States $0.171B 0.00
Taiwan Liposome (TLC) Taiwan $0.167B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.161B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.159B 0.00
IsoRay (ISR) United States $0.156B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.148B 0.00
Champions Oncology (CSBR) United States $0.148B 0.00
Heat Biologics (HTBX) United States $0.138B 0.00
Novan (NOVN) United States $0.137B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.135B 0.00
MediWound (MDWD) Israel $0.132B 0.00
Onconova Therapeutics (ONTX) United States $0.126B 0.00
Lipocine (LPCN) United States $0.101B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
Nutriband (NTRB) United States $0.097B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.093B 0.00
SCYNEXIS (SCYX) United States $0.084B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.079B 153.00
ElectroCore (ECOR) United States $0.076B 0.00
Biomerica (BMRA) United States $0.074B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.072B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.071B 0.00
Recro Pharma (REPH) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.068B 0.00
India Globalization Capital (IGC) United States $0.067B 0.00
AgeX Therapeutics (AGE) United States $0.066B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Vical (BBI) United States $0.060B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
Iterum Therapeutics (ITRM) Ireland $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.77
Regulus Therapeutics (RGLS) United States $0.046B 0.00
PolarityTE (PTE) United States $0.045B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.58
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.030B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.030B 0.00
KemPharm (KMPH) United States $0.027B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Flex Pharma (SLRX) United States $0.024B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 33.00
Bellicum Pharmaceuticals (BLCM) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00